Skip links

CASGEVY™ (exagamglogene autotemcel)

Full Name CASGEVY™ (exagamglogene autotemcel)
Drug Casgevy
Manufacturer Vertex Pharmaceuticals
Route of Administration Intravenous
Site of Care Healthcare Facility
Approved Indication Treatment of patients aged 12 years and older with:

  • Sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs)
  • Transfusion-dependent β-thalassemia (TDT)
Disease Sickle cell disease (SCD) and Transfusion-dependent β-thalassemia (TDT)
Therapeutic Area Hematology; Cell & Gene Therapy
Phone Number 1-833-837-8395